Standout Papers

Anti-TIGIT therapies for ... 2023 2026 2024 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. Anti-TIGIT therapies for solid tumors: a systematic review
    2023 89 citations Claudia Parisi, Fabrice Barlési et al. ESMO Open profile →

Immediate Impact

57 hit
Sub-graph 1 of 24

Citing Papers

Resistance mechanisms to immune checkpoint inhibitors: updated insights
2025 Hit
Cervical Cancer
2025 Hit
1 intermediate paper

Works of Claudia Parisi being referenced

Anti-TIGIT therapies for solid tumors: a systematic review
2023 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Claudia Parisi 429 392 367 338 230 46 1.2k
Alberto A. Diaz‐Arias 94 0.2× 403 1.0× 448 1.2× 324 1.0× 228 1.0× 55 1.4k
Kejian Guo 342 0.8× 113 0.3× 542 1.5× 295 0.9× 307 1.3× 49 1.2k
C Alvisi 265 0.6× 223 0.6× 712 1.9× 163 0.5× 227 1.0× 34 1.2k
Naondo Sohara 198 0.5× 512 1.3× 385 1.0× 256 0.8× 334 1.5× 49 1.2k
Francesco Paolo Pilato 113 0.3× 534 1.4× 358 1.0× 309 0.9× 189 0.8× 41 994
J. Fletcher 662 1.5× 143 0.4× 381 1.0× 151 0.4× 670 2.9× 36 1.4k
S A Watson 86 0.2× 265 0.7× 489 1.3× 383 1.1× 194 0.8× 34 1.1k
Toshihiro Suga 115 0.3× 339 0.9× 574 1.6× 312 0.9× 300 1.3× 61 1.4k
Pietro Caruana 341 0.8× 307 0.8× 785 2.1× 199 0.6× 301 1.3× 36 1.1k
Shih‐Pei Huang 323 0.8× 86 0.2× 730 2.0× 369 1.1× 315 1.4× 46 1.4k

All Works

Loading papers...

Rankless by CCL
2026